Agios Pharmaceuticals Inc (NASDAQ:AGIO)

86.99
Delayed Data
As of May 18
 +0.98 / +1.14%
Today’s Change
45.96
Today|||52-Week Range
89.33
+52.16%
Year-to-Date

Today’s Trading

Previous close86.01
Today’s open85.81
Day’s range85.30 - 87.16
Volume221,094
Average volume (3 months)530,310
Market cap$5.0B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)-33.14%
Earnings growth (this year)+3.72%
Earnings growth (next 5 years)--
Revenue growth (last year)-38.46%
P/E ratioNM
Price/Sales61.92
Price/Book11.31

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-1.30-0.79%
ICPTIntercept Pharmaceut...+1.24+1.74%
HCMHutchison China Medi...0.000.00%
MDCOMedicines Co-0.23-0.71%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$1.66
Annual revenue (last year)$43.0M
Annual profit (last year)-$314.7M
Net profit margin-731.60%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
CFO &
Head-Corporate Development
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts